Cargando…

Effects of a Group-Mediated Cognitive Behavioral Lifestyle Intervention on Select Social Cognitive Outcomes in Prostate Cancer Patients Undergoing Androgen Deprivation Therapy

Objective. To compare the effects of a group-mediated cognitive behavioral (GMCB) exercise and dietary (EX+D) intervention with those of standard-of-care (SC) treatment on select social cognitive outcomes in prostate cancer (PCa) patients undergoing androgen deprivation therapy (ADT). Methods. In th...

Descripción completa

Detalles Bibliográficos
Autores principales:	Focht, Brian C., Lucas, Alexander R., Grainger, Elizabeth, Simpson, Christina, Fairman, Ciaran M., Thomas-Ahner, Jennifer M., Chaplow, Zachary L., DeScenza, Victoria R., Bowman, Jessica, Clinton, Steven K.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2019
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6913059/ https://www.ncbi.nlm.nih.gov/pubmed/31838879 http://dx.doi.org/10.1177/1534735419893764

Ejemplares similares

Social cognitive outcomes are associated with improvements in mobility performance following lifestyle intervention in prostate cancer patients undergoing androgen deprivation therapy
por: Chaplow, Zachary L., et al.
Publicado: (2022)

Effects of a lifestyle intervention on body composition in prostate cancer patients on androgen deprivation therapy
por: Chaplow, Zachary L., et al.
Publicado: (2020)

Design and methods of a translational, community-based, lifestyle weight management pilot intervention trial in breast cancer survivors with overweight or obesity
por: Haynam, Marcy L., et al.
Publicado: (2023)

The Individualized Diet and Exercise Adherence Pilot Trial (IDEA-P) in prostate cancer patients undergoing androgen deprivation therapy: study protocol for a randomized controlled trial
por: Focht, Brian C, et al.
Publicado: (2014)

Effect of a Telephone-Based Lifestyle Intervention on Weight, Body Composition, and Metabolic Biomarkers in Rural Ohio: Results from a Randomized Pilot Study
por: Zhang, Xiaochen, et al.
Publicado: (2023)

The feasibility of a telephone-based weight loss intervention in rural Ohio: A pilot study
por: Zhang, Xiaochen, et al.
Publicado: (2023)

Androgen deprivation and cognition in prostate cancer
por: Salminen, E, et al.
Publicado: (2003)

Does Androgen Deprivation for Prostate Cancer Affect Normal Adaptation to Resistance Exercise?
por: Nilsen, Tormod S., et al.
Publicado: (2022)

Examining the effects of creatine supplementation in augmenting adaptations to resistance training in patients with prostate cancer undergoing androgen deprivation therapy: a randomised, double-blind, placebo-controlled trial
por: Fairman, Ciaran M, et al.
Publicado: (2019)

Dietary interventions to improve body composition in men treated with androgen deprivation therapy for prostate cancer: a solution for the growing problem?
por: Umlauff, Lisa, et al.
Publicado: (2021)

Cognitive Impacts of Estrogen Treatment in Androgen-Deprived Males: What Needs to be Resolved
por: Wibowo, Erik
Publicado: (2017)

Increased cytokine gene expression and cognition risk associated with androgen deprivation therapy
por: Verma, Shiv, et al.
Publicado: (2022)

Impact of Androgen Deprivation on Oxidative Stress and Antioxidant Status in Nigerian Patients With Prostate Cancer Undergoing Androgen Deprivation Therapy
por: Bassey, Iya Eze, et al.
Publicado: (2020)

Psychological distress in men with prostate cancer undertaking androgen deprivation therapy: modifying effects of exercise from a year-long randomized controlled trial
por: Galvão, Daniel A., et al.
Publicado: (2021)

Persistent androgen receptor-mediated transcription in castration-resistant prostate cancer under androgen-deprived conditions
por: Decker, Keith F., et al.
Publicado: (2012)

Androgen deprivation therapy and risk of cognitive dysfunction in men with prostate cancer: is there a possible link?
por: Shim, Myungsun, et al.
Publicado: (2022)

Effect of androgen deprivation therapy on cognitive functioning in men with prostate cancer: A systematic review
por: Andela, Cornelie D, et al.
Publicado: (2021)

Androgen-deprivation therapy and cognitive decline in the NEON-PC prospective study during the COVID-19 pandemic
por: Araújo, N., et al.
Publicado: (2022)

Does exercise impact gut microbiota composition in men receiving androgen deprivation therapy for prostate cancer? A single-blinded, two-armed, randomised controlled trial
por: Newton, Robert U, et al.
Publicado: (2019)

Efficacy of walking exercise in promoting cognitive-psychosocial functions in men with prostate cancer receiving androgen deprivation therapy
por: Lee, C Ellen, et al.
Publicado: (2012)

How Does Androgen Deprivation Therapy Affect Mental Health including Cognitive Dysfunction in Patients with Prostate Cancer?
por: Lee, Hyung Ho, et al.
Publicado: (2021)

Cognitive Dysfunction in Patients Treated with Androgen Deprivation Therapy: A Multimodality Functional Imaging Study to Evaluate Neuroinflammation
por: Saleem, Azeem, et al.
Publicado: (2023)

Androgen deprivation therapy and Gleason grade: unravelling implications on survival
por: Scott, Michael, et al.
Publicado: (2019)

Better Understanding the Timing Of Androgen Deprivation Trial Outcomes: Impacts of Prior Androgen Deprivation Therapy
por: Stensland, Kristian D, et al.
Publicado: (2022)

Efficacy of zoledronic acid in older prostate cancer patients undergoing androgen deprivation therapy
por: Kojima, Ippei, et al.
Publicado: (2019)

Prostate cancer, insulin, and androgen deprivation therapy
por: Stattin, P, et al.
Publicado: (2003)

Effects of vortioxetine on hippocampal-related cognitive impairment induced in rats by androgen deprivation as a model of prostate cancer treatment
por: Vaiana, Alexandra M., et al.
Publicado: (2023)

The effect of continuous androgen deprivation treatment on prostate cancer patients as compared with intermittent androgen deprivation treatment
por: Ku, Ja Yoon, et al.
Publicado: (2015)

Lifestyle aspects in a contemporary middle-European cohort of patients undergoing androgen deprivation therapy for advanced prostate cancer: data from the non-interventional LEAN study
por: Schmitz-Dräger, Bernd J., et al.
Publicado: (2023)

Assessing salivary matrix metalloproteinase‐8 in prostate cancer patients undergoing androgen deprivation therapy
por: Memon, Maaz A., et al.
Publicado: (2022)

Epidemiological profile of COVID-19 in patients with prostate cancer undergoing androgen deprivation therapy at a Brazilian Cancer Center
por: Travalini, Isabela Granato, et al.
Publicado: (2023)

Effects of a lifestyle intervention on endothelial function in men on long-term androgen deprivation therapy for prostate cancer
por: Gilbert, Stephen E, et al.
Publicado: (2016)

Sleep deprivation: Impact on cognitive performance
por: Alhola, Paula, et al.
Publicado: (2007)

The consequences of sleep deprivation on cognitive performance
por: Khan, Mohammad A., et al.
Publicado: (2023)

Androgen Deprivation Therapy and Cardiovascular Risk
por: Mourmouris, Panagiotis, et al.
Publicado: (2012)

Metabolic effects of androgen deprivation therapy
por: Choi, See Min, et al.
Publicado: (2015)

Cardiovascular Toxicities of Androgen Deprivation Therapy
por: Challa, Azariyas A., et al.
Publicado: (2021)

CARDIOVASCULAR DISEASES AND ANDROGEN DEPRIVATION THERAPY
por: Boban, Marko
Publicado: (2019)

Cardiovascular Toxicity of Androgen Deprivation Therapy
por: Boland, Julia, et al.
Publicado: (2021)

Lifestyle guidelines for managing adverse effects on bone health and body composition in men treated with androgen deprivation therapy for prostate cancer: an update
por: Owen, P J, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_2u0njhdi1puh6j67ajmsebkdkk